Mallinckrodt plc Ordinary Share (NYSE:MNK):
Mallinckrodt to present at Jefferies 2016 London Healthcare Conference.
The company is trading down since yesterday’s close of $63.04.
The stock is trading at $61.38 a bit lower than the 50 day moving average which is $69.45 and which is just a bit below the 200 day moving average of $66.80. The 50 day moving average moved down $-8.07 and the 200 day average was down $-5.42.
Mallinckrodt plc Ordinary Share’s P/E ratio is 11.57 and the market cap is 6.61B. In the last earnings report the EPS was $5.30 and is projected to be $7.64 for the current year with 107,713,000 shares now outstanding. Next quarter’s EPS is forecasted to be $1.90 with next year’s EPS anticipated to be $8.09.
A few analysts have released ratings on the stock of late. On August 31 Deutsche Bank made no change to the company rating of “Buy” and lowered the price target to $84.00 from $87.00. August 25 investment analysts at Barclays left the stock rating at “Overweight” but moved up the price target from $80.00 to $112.00.
On August 24 Piper Jaffray held the company rating at “Overweight” but raised the price target to $112.00 from $102.00. On August 12, 2016 Stifel Nicolaus starting coverage on MNK by announcing an initial rating of “Buy”.
BMO Capital began coverage of MNK with a rating of “Outperform”. May 4 investment analysts at JP Morgan left the company rating at “Neutral” and lowered the price expectation from $120.00 to $85.00.